| Patents for C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group (62,587) |
|---|
| 02/28/2007 | EP1756072A2 Purification of progesterone receptor modulators |
| 02/28/2007 | EP1756069A2 Hiv integrase inhibitors |
| 02/28/2007 | EP1756063A1 Amido compounds and their use as pharmaceuticals |
| 02/28/2007 | EP1756060A1 Therapeutic compounds: pyridine as scaffold |
| 02/28/2007 | EP1756056A1 Aza-bicyclo[3.1.0]hex-1-yl derivatives active as nk1 antagonists |
| 02/28/2007 | EP1756051A1 Histamine h3 receptor agents, preparation and therapeutic uses |
| 02/28/2007 | EP1626962B1 Benzamide inhibitors of the p2x7 receptor |
| 02/28/2007 | EP1507776B1 2-oxo-1,3,4-trihydroquinazolinyl derivatives for the treatment of cell proliferation-related disorders |
| 02/28/2007 | EP1501795B1 Cinnamic acid amides |
| 02/28/2007 | EP1441734B1 Dihydroxypyrimidine carboxamide inhibitors of hiv integrase |
| 02/28/2007 | EP1397350B1 Isoquinolinone derivatives as parp inhibitors |
| 02/28/2007 | EP1368094B1 4-(2-butylamino)-2,7-dimethyl-8-(2-methyl-6-methoxypyrid-3-yl) pyrazolo- 1,5-a|-1,3,5-triazine, its enantiomers and pharmaceutically acceptable salts as corticotropin releasing factor receptor ligands |
| 02/28/2007 | EP1265606B9 Cell adhesion inhibitors |
| 02/28/2007 | EP1240154B1 Serine protease inhibitors |
| 02/28/2007 | EP1102753B1 Pyrazoles as estrogen receptor modulators |
| 02/28/2007 | CN1922180A Inhibitors of cyclin-dependent kinases, compositions and uses related thereto |
| 02/28/2007 | CN1922174A 病毒聚合酶抑制剂 Viral polymerase inhibitor |
| 02/28/2007 | CN1922159A Benzamide derivatives and their use as glucokinase activating agents |
| 02/28/2007 | CN1922156A Substituted triazoles as sodium channel blockers |
| 02/28/2007 | CN1922151A Substituted azole derivatives, compositions, and methods of use |
| 02/28/2007 | CN1922141A Novel heterocyclic compound |
| 02/28/2007 | CN1922139A Bicyclic amide derivatives |
| 02/28/2007 | CN1921848A Novel azabicyclic derivatives, preparation method thereof and pharmaceutical compositions containing same |
| 02/28/2007 | CN1919846A Novel oriented synthesis method of voriconazole, medicinal salt and intermediate thereof |
| 02/28/2007 | CN1919845A Compound containing tetrazine polynitrobenzene and synthesis method thereof |
| 02/28/2007 | CN1919841A Synthetic intermediate of Irbesartan, preparation method and use thereof |
| 02/28/2007 | CN1301992C Pyrazolyl pyrimidines |
| 02/28/2007 | CN1301975C 1,2-diaryl benzimidazole derivative for treating illnesses associated with microglia activation |
| 02/28/2007 | CN1301973C Heterocyclic derivatives and medicines |
| 02/28/2007 | CN1301969C New mandelic acid derivatives and their use as thrombin inhibitors |
| 02/27/2007 | US7183410 1-(2-(4-(3-trifluoromethyl-phenyl)piperazin-1-yl) ethyl)-2,3-dihydro-1H-benzimidazol-2-one (flibanserin) useful for treating psychological and nerveous system disorders |
| 02/27/2007 | US7183374 Diminishing concentration of metal complex from solution containing the complex by addition of an optionally fused and/or optionally substituted heterocyclic compound which is a solubility-enhancing compound that enhances solubility of complex in second solution |
| 02/27/2007 | US7183312 Compounds for use as antigrowth agents or antitumor agents and with solvents |
| 02/27/2007 | US7183307 Pyrazole-derived kinase inhibitors and uses thereof |
| 02/27/2007 | US7183306 Pyrazole derivatives |
| 02/27/2007 | US7183304 Heterocyclic compounds and methods of use |
| 02/27/2007 | US7183296 Anti-HIV pyrazole derivatives |
| 02/27/2007 | US7183290 Fluoropyrrolidines as dipeptidyl peptidase inhibitors |
| 02/27/2007 | US7183288 2-phenylamino-4-pyrimidinecarboxamides; coupling a phenylamine with a halopyrimidine, or coupling a halobenzene with an aminopyrimidine, or amidating the 2-phenylamino-4-pyrimidylacylhalide, or oxidizing the 2-phenylamino-4-cyanopyrimidine |
| 02/27/2007 | US7183287 Substituted pyrimidinones |
| 02/27/2007 | US7183284 Aminium salts of 1,2,3-triazoles as prodrugs of drugs including antiviral agents |
| 02/27/2007 | US7183281 Sulfonylquinoxalone derivatives and related compounds as bradykinin antagonists |
| 02/27/2007 | US7183279 Synergistic combinations with morphine; analgesics and cyclooxygenase-2 inhibitors, such as N-5-guanidinopentanamide-(2S)-yl-2-N-(p-hydroxyphenylacetyl)phenylenediamine and N-5-guanidinopentanamide-(2R)-yl-2-N-(p-hydroxybenzyl)-5-carboxybenzimidazole |
| 02/27/2007 | US7183277 Alpha-((aryl or heteroaryl)ureido or carbamoyloxy)-N-heteroaryl amides; blood-coagulation factor Xa and VIIa inhibitors; synergistic mixtures with other antitumor agents or anticoagulants |
| 02/27/2007 | US7183274 Piperidine-2,6-diones heterocyclically substituted in the 3-position |
| 02/27/2007 | US7183270 Cyclic derivatives as modulators of chemokine receptor activity |
| 02/23/2007 | WO2007021308A1 Metabotropic glutamate-receptor-potentiating isoindolones |
| 02/22/2007 | WO2007022371A2 Chemokine receptor binding compounds |
| 02/22/2007 | WO2007022280A1 Phosphodiesterase 10 inhibitors |
| 02/22/2007 | WO2007021991A2 Melanocortin receptor-specific piperazine and keto-piperazine compounds |
| 02/22/2007 | WO2007021990A2 Melanocortin receptor-specific piperazine compounds with diamine groups |
| 02/22/2007 | WO2007021966A1 Pyrazole compounds that modulate hsp90 activity |
| 02/22/2007 | WO2007021877A1 Imidazole compounds that modulate hsp90 activity |
| 02/22/2007 | WO2007021794A1 Substituted imidazole compounds as ksp inhibitors |
| 02/22/2007 | WO2007021711A2 Substituted-3-sulfonylindazole derivatives as 5-hydroxytryptamine-6 ligands |
| 02/22/2007 | WO2007021573A1 Substituted piperazines as metabotropic glutamate receptor antagonists |
| 02/22/2007 | WO2007021309A1 Substituted isoindolones and their use as metabotropic glutamate receptor potentiators |
| 02/22/2007 | WO2007020936A1 Bicyclo heterocyclic compound having antifungal action |
| 02/22/2007 | WO2007020654A1 An improved process for the preparation of losartan |
| 02/22/2007 | WO2007020533A2 Process for the preparation of losartan potassium |
| 02/22/2007 | WO2007020502A2 Cannabinoid receptor ligands and uses thereof |
| 02/22/2007 | WO2007020426A1 Pyrazolone derivatives for the treatment of tuberculosis |
| 02/22/2007 | WO2007020411A1 Amide derivatives |
| 02/22/2007 | WO2007020194A1 Piperidine and piperazine derivatives as p2x3 antagonists |
| 02/22/2007 | WO2007020190A1 Fluoro substituted 2-oxo azepan derivatives |
| 02/22/2007 | WO2007020046A1 Benzoquinazoline derivatives and their use in treating bone disorders |
| 02/22/2007 | WO2007019867A1 Novel 2,3-dihydroindole compounds |
| 02/22/2007 | WO2007000550A3 Novel indoline compounds |
| 02/22/2007 | WO2006133006A3 1-methyl-1h-pyrazole-4-carboxamides useful as cancer chemotherapeutic agents |
| 02/22/2007 | WO2006105051A3 Synthesis of diketopiperazines |
| 02/22/2007 | WO2006078941A3 Novel sirtuin activating compounds and methods of use thereof |
| 02/22/2007 | US20070043101 [4-({5-[(1,1'-biphenyl-4-ylsulfonyl)amino]-1H-indol-1-yl}methyl)phenoxy]acetic acid; inhibiting PAI-1 activity; treat impairment of the fibrinolytic system; thrombosis; cardiovascular disease; chronic obstructive pulmonary disease, renal fibrosis, polycystic ovary syndrome, Alzheimer's disease, cancer |
| 02/22/2007 | US20070043098 Process for the preparation of tetrazole derivatives from organo boron and organo aluminium azides |
| 02/22/2007 | US20070043085 Process for the preparation of amorphous form of neutral esomeprazole |
| 02/22/2007 | US20070043084 1,2-Diarylimidazoles useful as inhibitors of cox |
| 02/22/2007 | US20070043081 N-Cyclopropyl-N-(1-{2-[3-(2,6-dimethyl-pyridin-4-yl)-ureido]-ethyl}-piperidin-4-yl)-2-fluoro-benzenesulfonamide; 2-(4-Chloro-phenyl)-N-(1-{2-[3-(2,6-dimethyl-pyridin-4-yl)-ureido]-ethyl}-piperidin-4-yl)-N-methyl-acetamide; neurohormonal antagonists |
| 02/22/2007 | US20070043065 Amide derivatives |
| 02/22/2007 | US20070043058 Novel 2,3-dihydroindole compounds |
| 02/22/2007 | US20070043056 5-Substituted-2-arylpyrazines |
| 02/22/2007 | US20070043053 for treating p38 kinase-associated conditions like inflammatory disorders; improved dissolution rate and oral bioavailability; rheumatic diseases; skin disorders; multiple sclerosis; osteoporosis; Alzheimer's disease |
| 02/22/2007 | US20070043051 Methods and compositions of novel triazine compounds |
| 02/22/2007 | US20070043048 Such as 2-methyl-4-{5-[2-(2,2,6,6-tetramethyl-piperidin-4-ylamino)-pyrimidin-4-yl]-thiophen-2-yl}-butan-2-ol; tumor necrosis factor inhibitors; immunosuppressants; antiinflammatory agents |
| 02/22/2007 | US20070043043 Benzimidazole derivates: preparation and pharmaceutical applications |
| 02/22/2007 | US20070043042 Quinoline potassium channel inhibitors |
| 02/22/2007 | US20070043041 Indol-6 sulfonamide derivative, their preparation and their use 5-ht-6 as modulators |
| 02/22/2007 | US20070043038 Indolone-acetamide derivatives, processes for preparing them and their uses |
| 02/22/2007 | US20070043037 Pyrimidine derivatives as orexin receptor antagonists |
| 02/22/2007 | US20070043036 2-Pyridone derivatives as neutrophil elastase inhibitors and their use |
| 02/22/2007 | US20070043028 Compositions of novel opioid compounds and method of use thereof |
| 02/22/2007 | US20070043017 Ring-substituted diphenylazetidinones, process for their preparation, medicaments comprising these compounds, and their use |
| 02/22/2007 | US20070043016 Method of treating fibrotic diseases or other indications with imidazolium agents |
| 02/22/2007 | US20070043015 Phenyl pyrrolidine ether tachykinin receptor antagonists |
| 02/22/2007 | US20070043013 1,3 Disubstituted azetidine derivatives for use as ccr-3 receptor antagonists in the treatment of inflammatory and allergic diseases |
| 02/22/2007 | US20070043011 Substituted benzanilide compound and noxious organism controlling agent |
| 02/22/2007 | US20070043010 Quinazoline derivatives |
| 02/22/2007 | US20070042996 N-alkynyl-2-(substituted aryloxy) alkylthioamine derivatives as fungicides |
| 02/22/2007 | US20070042398 Cyanine dyes and methods of use |
| 02/22/2007 | US20070041933 Functionally Diverse Macromolecules and Their Synthesis |
| 02/22/2007 | CA2619517A1 Pyrazine kinase inhibitors |
| 02/22/2007 | CA2619462A1 Phosphodiesterase 10 inhibitors |